Canntab Therapeutics signs deal to enter medicinal cannabis market in Mexico

Canntab Therapeutics Ltd. (CSE:PILL) CFO Richard Goldstein checked in with Steve Darling from Proactive Investors on Skype to discuss Canntab entering in to a non binding Letter of Intent with Labsco Promedic SA de CV of Monterrey, Mexico.

That deal is expected to be finalized by end of the year. Goldstein also updated the companies most recent partnerships and how they are going to work.

Leave a Comment